Physician profile
Robert Pellecchia
NPI 1104035211
$41,280.65
in general payments reported to CMS, 2019-2025
12 companies · $15K in 2025
The $15K reported for 2025 was more than what 99% of Oral and Maxillofacial Surgery providers received nationally (typical 2025 total: $150).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17K · 2020: $3,700 · 2021: $4,361 · 2022: $368 · 2023: $174 · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $14K · Travel and Lodging: $684 · Food and Beverage: $422.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $14,256.25 |
| Travel and Lodging | $683.82 |
| Food and Beverage | $421.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $23,299.35 | 2019-2025 | Traumaone |
| Straumann USA LLC | $14,256.25 | 2025 | |
| Stryker Corporation | $2,813.84 | 2021-2025 | Vsp System, Vsp Cranial, Patient-Fitted Tmj Reconstructive Prosthesis System |
| Axogen | $393.72 | 2019-2022 | |
| Depuy Synthes Sales INC. | $157.58 | 2020-2023 | Trumatch, Matrixmandible |
| Ortho Organizers, INC. | $87.46 | 2023 | Carriere |
| Biohorizons Implant Systems INC. | $82.34 | 2021 | |
| Dentsply Sirona INC | $66.67 | 2023 | Implant Dentistry |
| Zimvie INC. | $57.27 | 2025 | |
| Checkpoint Surgical, INC | $30.50 | 2021-2022 | |
| Acera Surgical, INC. | $22.40 | 2025 | Restrata Wound Matrix |
| Terumo Bct, INC. | $13.27 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Pellecchia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.